Theravance Biopharma, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. META
4. ABBV
5. SPY
6. IBM
7. NKE
8. MU
9. USO
10. NVDA

Go back to Theravance Biopharma, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update

Theravance Biopharma (TBPH) Misses Q2 EPS by 10c

August 4, 2022 4:56 PM EDT

Theravance Biopharma (NASDAQ: TBPH) reported Q2 EPS of ($0.11), $0.10 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $11.1 million versus the consensus estimate of $12.5 million.

For earnings history and earnings-related data on Theravance Biopharma (TBPH) click here.

... More